German life sciences company Rentschler Biopharma SE has appointed Christiane Bardroff as the company’s next chief operating officer, whose responsibilities include overseeing construction work at its Milford location, which is the site of U.S. operations.
Bardroff will begin in her new position on Dec. 1, according to the Tuesday announcement from the company. Rentschler Biopharma is a biopharmaceutical contract development and manufacturing organization with locations in Laupheim, Germany, Stevenage, England, and Milford.
Bardroff replaces Ralf Otto, who is now a partner at international business consultant McKinsey & Co., according to his LinkedIn profile.
Previously, Bardroff joined the company in 2022 as a senior vice president client program management and in May was named senior vice president of clinical and commercial manufacturing at the Laupheim site. Previously, she oversaw the construction of Teva Biotech GmbH’s automated, large-scale biotechnology production facility in Ulm, Germany.
